Overview

Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether maintenance renal transplant patients receiving Myfortic can reduce or discontinue GI prophylaxis medications.
Phase:
Phase 4
Details
Lead Sponsor:
East Carolina University
Collaborator:
Novartis
Treatments:
Mycophenolate mofetil